Position statementASGE position statement on endoscopic bariatric therapies in clinical practice
Section snippets
Program components
The program components for successful management of obesity by using EBT as an adjunctive tool to enhance weight loss with lifestyle intervention described in the following require a multidisciplinary approach. However, this can be delivered either through a center with all personnel practicing within the center or through referral networks outside of the endoscopist’s office.
Physician training and certification
The ASGE understands that some EBTs are extensions of current endoscopic skills but also may require specific and detailed training to incorporate into a bariatric program and to perform competently. It is the ASGE’s intention to offer comprehensive training to endoscopists who seek to perform endoscopic bariatric procedures.
Program recognition
Patients with obesity with or without comorbidities are best managed with a multidisciplinary approach that will address all aspects of the patient’s long-term weight management care and potential adverse events. EBTs need to be recognized as one potential component of a complex treatment program for patients with obesity. This will require endoscopists involved in EBT to be part of a multidisciplinary program able to provide lifestyle therapy, pharmacotherapy, or surgery in addition to EBT or
EBT registry
The ASGE supports the establishment of registries for EBT either by medical societies with an interest in EBT, industry, or the federal government. Accurate reporting to and regular analysis of a registry is essential to demonstrate the benefit of EBT in the clinical setting. Moreover, registries will allow for a more uniform quality analysis for a recognition program. All data regarding patient demographic characteristics, EBT performed, lifestyle therapy program provided, other adjunctive
Conclusion
The development and approval of effective and safe EBTs provide another adjunctive therapy for patients with obesity who are unable to manage the disease with lifestyle intervention alone. Obesity is a complex disorder that should be approached with the proper knowledge of the disease process and management options to improve successful treatment. Therapeutic expertise gained through appropriate training in EBT is important for endoscopists who offer it in their practice; however, the maximum
Disclosure
Dr Edmundowicz, Consultant (consulting fees), Advisory Board Member, Boston Scientific; Consultant (consulting fees), Advisory Board Member, Olympus; Stockholder, Medical Advisory Board Member, SynerZ Medical; Consultant (consulting fees), Research Advisory Committee Member, GI Dynamics; Consultant (consulting fees), Advisory Board Member, Fractyl; Consultant (Stock/Ownership interest), Beacon Endoscopic (now acquired by Medtronic); Contracted Research, site principle investigator or
References (66)
- et al.
A pathway to endoscopic bariatric therapies
Gastrointest Endosc
(2011) - et al.
The medical care costs of obesity: an instrumental variables approach
J Health Econ
(2012) - et al.
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet
(2010) - et al.
Bariatric surgery outcomes
Surg Clin North Am
(2011) - et al.
Endoscopic bariatric therapies
Gastrointest Endosc
(2015) - et al.
Effects of a vegetarian diet and treatment preference on biochemical and dietary variables in overweight and obese adults: a randomized clinical trial
Am J Clin Nutr
(2007) - et al.
Fitness vs. fatness on all-cause mortality: a meta-analysis
Prog Cardiovasc Dis
(2014) - et al.
Behavioral treatment of obesity
Med Clin North Am
(2000) - et al.
Methods of granting hospital privileges to perform gastrointestinal endoscopy
Gastrointest Endosc
(2002) - et al.
Principles of training in GI endoscopy
Gastrointest Endosc
(2012)
Renewal of and proctoring for endoscopic privileges
Gastrointest Endosc
Guidelines for safety in the gastrointestinal endoscopy unit
Gastrointest Endosc
Defining and measuring quality in endoscopy
Gastrointest Endosc
Prevalence of childhood and adult obesity in the United States, 2011-2012
JAMA
Morbid obesity rates continue to rise rapidly in the United States
Int J Obes
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis
JAMA
Body-mass index and mortality among 1.46 million white adults
N Engl J Med
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Lancet
Annual medical spending attributable to obesity: payer-and service-specific estimates
Health Affairs
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial
Obesity
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient–2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery
Obesity (Silver Spring)
Behavioral assessment of candidates for bariatric surgery: a patient-oriented approach
Obesity
One-year weight losses in the Look AHEAD study: factors associated with success
Obesity
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society
Circulation
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
N Engl J Med
Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II
Ann Intern Med
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial
Diabetes Care
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
Lancet
Association of an intensive lifestyle intervention with remission of type 2 diabetes
JAMA
Effects of weight loss in overweight/obese individuals and long-term lipid outcomes – a systematic review
Obes Rev
Long-term drug treatment for obesity: a systematic and clinical review
JAMA
Pharmacological management of obesity: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab
Cited by (70)
Psychosocial Aspects of Metabolic and Bariatric Surgeries and Endoscopic Therapies
2022, Gastroenterology Clinics of North AmericaCitation Excerpt :Importantly, EBMTs are proposed as adjunctive to lifestyle change and, in many cases, placed on a limited time frame (∼6–12 months), during which patients will benefit most from consistent lifestyle and behavioral changes to compliment the anatomic changes. Frequent contact with the support team (ie, RDs and psychologists) is therefore valuable in the ongoing monitoring of patients.75,76 Evidence suggests patients who undergo AT plus lifestyle counseling are more successful with weight loss compared with lifestyle change alone.76
Five-Year Outcomes of Endoscopic Sleeve Gastroplasty for the Treatment of Obesity
2021, Clinical Gastroenterology and HepatologyInterpretation of Expert consensus on digestive endoscopic treatment for obesity in China
2024, Chinese Journal of Digestive EndoscopySuccess Predictors of Endoscopic Sleeve Gastroplasty
2024, Obesity SurgeryUpdate on Endoscopic Treatments for Obesity
2024, Current Obesity Reports
This document was reviewed and approved by the Governing Board of the American Society for Gastrointestinal Endoscopy.